CFS is not a mystery, but the consequence of chronic infections by intracellular bacteria such as rickettsiae.
CFS (Chronic Fatigue Syndrome), also known as Myalgic Encephalomyelitis (ME), refers to a state of persistent, severe exhaustion without adequate other explanation. Affected individuals feel permanently ill, powerless and mentally as well as physically exhausted, even after adequate sleep.
Our View:
CFS arises from a kind of cellular energy deficiency state, caused by invading intracellular bacteria such as rickettsiae, which disrupt cellular metabolism.
The Effects of Intracellular Bacteria
CFS is not 'giving up'. It is the daily struggle of a body crushed by invisible burdens. We fight for the recognition of this biological reality.
CFS manifests through characteristic symptoms that severely impact patients' lives.
Recent research supports the infection hypothesis in CFS.
University of Newcastle, Australia
Characteristic metabolic profiles in CFS patients suggesting the body is fighting a chronic infection.
South Africa - 3000 CFS patients
Rickettsia infections detected in CFS patients and successfully treated with special antibiotics (tetracyclines).
Significant improvement of symptoms through antimicrobial therapy
Behind the diagnosis of CFS often lies an undetected chronic infection. We must look deep to find the true causes of fatigue.
Various intracellular pathogens can trigger CFS.
Intracellular bacteria
Vascular damage and immune deficiency
Spirochete bacteria
Neurological and systemic inflammation
Herpes virus
Immune system exhaustion
Intracellular bacteria
Chronic inflammatory response
Untreated CFS can lead to various chronic diseases.
CFS is reversible if the underlying infection is found and treated early. When the triggering infections are found and treated, health status can improve dramatically.
Long COVID shows strong similarities to classic ME/CFS and confirms the infection hypothesis.
Long COVID and ME/CFS show striking similarities in symptoms: extreme fatigue, cognitive impairment, and post-exertional malaise.
Both conditions show similar biomarkers such as elevated inflammatory markers, disrupted cellular energy production, and autoimmune reactions.
Long COVID research opens new treatment pathways for both conditions and confirms the infection hypothesis.
This scientific information is provided for educational and patient guidance purposes only. It does not constitute medical advice, individualized diagnosis, or a promise of cure, and cannot replace a personal consultation with a qualified physician.
Association for the Treatment of Chronic Infections (VBCI e.V.) – Non-Profit Patient Organization.
Chronic infections require in-depth knowledge and individual solutions. Our experts guide you toward the right diagnosis.
When you contact us, we treat your data confidentially. Please read our privacy policy regarding the processing of personal data. By contacting us, you agree to this.